The present invention relates generally to a system and method for aseptically transferring fluid, and more particularly but not exclusively to a system and method for aseptically transferring a liquid substance from a vial to a receiving container.
Contamination during manufacturing of biopharmaceutical products may have serious health effects on patients, especially biologics that are introduced to the patients by injection because this mode of drug delivery may bypass the body's natural defenses. Accordingly, biologics are manufactured in aseptic processing facilities that require cleanrooms with stringent controls and close monitoring to minimize the risks of microbial and pyrogen contamination. The strict requirements on sterility and cleanliness during manufacturing have prompted the biopharmaceutical industry to increasingly use closed processing systems equipped with single-use technologies. The use of such closed processing systems to manufacture biologics, however, still requires aseptic transfer of ingredients from containers, such as common glass vials sealed by septa, to the processing systems. Glass vials are considered to be standard containers in the pharmaceutical industry owing to their extensive clinical history and long term stability with various drugs. The transfer process of ingredients from vials to closed processing systems may still need to be performed in a cleanroom with a stringent sterility and cleanliness standard, which will inevitably inflate the manufacturing cost of biologics.
For the foregoing reason, there is a need for a system and method for aseptically transferring a liquid substance from a vial to a receiving container of a processing system or equipment.
The present invention is directed to a system that satisfies this need. A system having features of the present invention for aseptically transferring a liquid substance comprises a sterilized vial filled with the liquid substance and sealed with a sterilized septum; a sterilized fluidic assembly comprising a piercing member including therein first and second channels and having a tip end that operably punctures the sterilized septum, the first and second channels having first and second channel openings at the tip end of the piercing member; a manual air pump; an inlet line fluidically connects the manual air pump to the first channel of the piercing member; and an outlet line fluidically connected to the second channel of the piercing member at one end and hermetically sealed at the other end; and a sterilized pouch enclosing and hermetically sealing the sterilized vial and the piercing member and operably allowing the piercing member to puncture the sterilized septum without breaching the sterilized pouch when one of the sterilized vial and the piercing member is manually pushed against the other one of the sterilized vial and the piercing member from an exterior of the sterilized pouch.
According to another aspect of the present invention, a method having features of the present invention for manufacturing a system for aseptically transferring a liquid substance comprises the steps of sterilizing a vial and a septum; aseptically filling the sterilized vial with the liquid substance and sealing the sterilized vial with the sterilized septum; providing a fluidic assembly that includes a piercing member including therein first and second channels and having a tip end that operably punctures the sterilized septum, the first and second channels having first and second channel openings at the tip end of the piercing member; a manual air pump; an inlet line fluidically connects the manual air pump to the first channel of the piercing member; and an outlet line fluidically connected to the second channel of the piercing member at one end and hermetically sealed at the other end; sterilizing the fluidic assembly; and assembling the vial and the fluidic assembly and hermetically sealing the vial and the piercing member in a sterilized pouch in an aseptic environment, wherein the sterilized pouch allows the piercing member to puncture the sterilized septum without breaching the sterilized pouch when one of the sterilized vial and the piercing member is manually pushed against the other one of the sterilized vial and the piercing member from an exterior of the sterilized pouch.
According to still another aspect of the present invention, a method having features of the present invention for aseptically transferring a liquid substance comprises the steps of providing a transfer system including a sterilized vial filled with the liquid substance and sealed with a sterilized septum; a sterilized fluidic assembly including a piercing member including therein first and second channels and having a tip end that operably punctures the sterilized septum, the first and second channels having first and second channel openings at the tip end of the piercing member; a manual air pump filled with sufficient air to propel all of the liquid substance out of the sterilized vial; an inlet line fluidically connects the manual air pump to the first channel of the piercing member; and an outlet line fluidically connected to the second channel of the piercing member at one end and hermetically sealed at the other end; and a sterilized pouch enclosing and hermetically sealing the sterilized vial and the piercing member; aseptically connecting the outlet line to an external line for receiving the liquid substance; puncturing the sterilized septum with the piercing member by manually pushing one of the sterilized vial and the piercing member against the other one of the sterilized vial and the piercing member from an exterior of the sterilized pouch without breaching the sterilized pouch, thereby aseptically establishing fluidic connections between the sterilized vial and the inlet and outlet lines; and expelling air from the manual air pump into the sterilized vial disposed in an inverted orientation to propel the liquid substance in the sterilized vial through the outlet line and into the external line.
These and other features, aspects, and advantages of the present invention will become better understood with regard to the following description, appended claims, and accompanying drawings where:
For purposes of clarity and brevity, like elements and components will bear the same designations and numbering throughout the Figures, which are not necessarily drawn to scale.
In the Summary above and in the Detailed Description, and the claims below, and in the accompanying drawings, reference is made to particular features (including method steps) of the invention. It is to be understood that the disclosure of the invention in this specification includes all possible combinations of such particular features. For example, where a particular feature is disclosed in the context of a particular aspect or embodiment of the invention, or a particular claim, that feature can also be used, to the extent possible, in combination with and/or in the context of other particular aspects and embodiments of the invention, and in the invention generally.
Where reference is made herein to a method comprising two or more defined steps, the defined steps can be carried out in any order or simultaneously, except where the context excludes that possibility, and the method can include one or more other steps which are carried out before any of the defined steps, between two of the defined steps, or after all the defined steps, except where the context excludes that possibility.
The term “biological objects” as used herein includes cells, bacteria, viruses, molecules, particles including RNA and DNA, cell cluster, bacteria cluster, molecule cluster, and particle cluster.
The term “biological sample” as used herein includes blood, body fluid, tissue extracted from any part of the body, bone marrow, hair, nail, bone, tooth, liquid and solid from bodily discharge, or surface swab from any part of body. “Fluid sample,” or “sample fluid,” or “liquid sample,” or “sample solution” may include a biological sample in its original liquid form, biological objects being dissolved or dispersed in a buffer fluid, or a biological sample dissociated from its original non-liquid form and dispersed in a buffer fluid. A buffer fluid is a liquid into which biological objects may be dissolved or dispersed without introducing contaminants or unwanted biological objects. Biological objects and biological sample may be obtained from human or animal. Biological objects may also be obtained from plants and environment including air, water, and soil. A fluid sample may contain various types of magnetic or optical labels, or one or more chemical reagents that may be added during various process steps.
The term “sample flow rate” or “flow rate” is used herein to describe the volume amount of a fluid flowing through a cross section of a channel, a conduit, a fluidic part, a fluidic path, or a fluidic line in a unit time.
The term “at least” followed by a number is used herein to denote the start of a range beginning with that number, which may be a range having an upper limit or no upper limit, depending on the variable being defined. For example, “at least 1” means 1 or more than 1. The term “at most” followed by a number is used herein to denote the end of a range ending with that number, which may be a range having 1 or 0 as its lower limit, or a range having no lower limit, depending upon the variable being defined. For example, “at most 4” means 4 or less than 4, and “at most 40%” means 40% or less than 40%. When, in this specification, a range is given as “a first number to a second number” or “a first number-a second number,” this means a range whose lower limit is the first number and whose upper limit is the second number. For example, “25 to 100 nm” means a range whose lower limit is 25 nm and whose upper limit is 100 nm.
Directional terms, such as “front,” “back,” “top,” “bottom,” and the like, may be used with reference to the orientation of the illustrated figure. Spatially relative terms, such as “beneath,” “below,” “under,” “lower,” “upper,” “above,” etc., may be used herein to describe one element's relationship to another element(s) as illustrated in the figure. Since articles and elements can be positioned in a number of different orientations, these terms are intended for illustration purposes and in no way limit the invention, except where the context excludes that possibility.
The first and second channels 60, 62 have first and second channel openings at the tip end 64 of the piercing member 58, respectively. The other ends the first and second channels 60, 62 are connected to the inlet and outlet lines 72, 74, respectively. When the piercing member 58 punctures through the septum 56 at the time of use, the first and second channel openings at the tip end 64 will be exposed to the interior or chamber of the sterilized vial 52, thereby fluidically connecting the interior or chamber of the sterilized vial 52 to the outlet line 74 and the manual air pump 66 through the inlet line 72.
The system 50 may further comprise a sterilized holder 70, onto which the sterilized vial 52 and the piercing member 58 are mounted. The sterilized holder 70, together with the sterilized vial 52 and the piercing member 58, may be hermetically sealed in the sterilized pliable container 68 and may provide a guiding means or mechanism for the piercing member 58 to puncture the sterilized septum 56 in the sterilized pliable container 68 without breaching the sterilized pliable container 68 when one of the sterilized vial 52 and the piercing member 58 is manually pushed against the other one of the sterilized vial 52 and the piercing member 58 from the exterior of the sterilized pliable container 68.
The fluidic assembly of the system 50 may further comprise an air filter 78 inserted along the inlet line 72 for filtering the air discharged from the manual air pump 66, thereby preserving the sterility of air entering the sterilized vial 52, and/or an optional check valve 80 inserted along the inlet line 72 to prevent the back flow of air to the manual air pump 66, and/or another optional check valve 82 inserted along the outlet line 74 to prevent back flow of the liquid substance 54 to the sterilized vial 52 during the transfer operation, and/or additional connectors inserted along the inlet and outlet lines 72, 74.
The sterilized vial 52 may be made of glass and sealed by the sterilized septum 56 comprising an elastomeric material, such as but not limited to polytetrafluoroethylene (PTFE) or PTFE/silicone/PTFE laminates. The sterilized septum 56 may be held in place by a retainer (not shown) extending around the neck of the sterilized vial 52, and particularly around a collar or flange formed on the neck of the sterilized vial 52. The retainer may also extend partially over the exterior surface of the sterilized septum 56 to leave an exposed region of the sterilized septum 56 for access to the interior or chamber of the sterilized vial 52 with the piercing member 58. The sterilized vial 52 itself without the liquid substance 54 therein and the sterilized septum 56 may be sterilized by any suitable sterilization method, such as but not limited to steam sterilization, chemical sterilization, e-beam sterilization, or gamma ray radiation sterilization, prior to filling the sterilized vial 52 with the liquid substance 54 under an aseptic or sterile condition to prevent potential contamination.
The liquid substance 54 may comprise any substance or ingredient used in manufacturing of biologics, such as but not limited to water, buffer, cell culture media, serum, freeze media, transduction enhancer (e.g., peptide, polymer), protein (e.g., IL2, IL-15, or antibody), magnetic beads-antibody conjugates for cell sorting (i.e., magnetic labels), lipid nano-particles, plasmids, virus, cells, extravascular suspension, or any combination thereof.
The piercing member 58 of the sterilized fluidic assembly may be made of a metallic, ceramic, or polymeric material that is sufficiently hard for puncturing through the elastomeric septum 56. For example and without limitation, the piercing member 58 may be made of stainless steel. The inlet line 72 and outlet line 74 of the sterilized fluidic assembly may be made of a pliable/flexible thermoplastic material, such as but not limited to polyvinyl chloride (PVC). The free end of the outlet line 74 may be hermetically sealed by heat-induced welding. Prior to transferring the liquid substance 54 out of the sterilized vial 52, the free end of the outlet line 74 may be aseptically welded to another line connected to a receiving container (not shown), thereby aseptically transferring the liquid substance 54 to the receiving container. Alternatively, the free end of the outlet line 74 may be hermetically sealed by a male or female half of an aseptic connector 76, which is then connected to the opposite half of the aseptic connector attached to another line at the time of use. The male and female halves of the aseptic connector 76 each contain a sterile membrane, which is removed when the male and female halves are joined together, thereby forming a closed and sterile fluid path between the lines at the opposite ends of the aseptic connector 76.
The manual air pump 66 of the fluidic assembly may be in the form of a syringe, which includes a barrel and a plunger, or any air bladder device filled with sufficient air to propel substantially all of the liquid substance 54 out of the sterilized vial 52. The syringe or air bladder device may be manually squeezed by hand to push the air therein into the sterilized vial 52, thereby propelling the liquid substance 54 into the outlet line 74. The manual air pump 66 may alternatively be replaced by a portable air pump powered by battery or electricity to inject air into the sterilized vial 52.
The sterilized fluidic assembly, which includes the piercing member 58, the inlet line 72, the manual air pump 66, the outlet line 74, the optional air filter 78, and the optional check valves 80, 82 may be sterilized by heat, steam, gamma ray radiation, or other suitable means.
The sterilized pliable container 68 may be in the form of a bag or pouch and is sufficiently supple and resilient to allow the piercing member 58 to puncture the septum 56 by manual manipulation from outside of the sterilized pliable container 68 without breaking or tearing the sterilized pliable container 68, thereby ensuring the interior of the sterilized pliable container 68 and all fluidic paths in the sterilized fluidic assembly remain sterile after establishing fluidic communication between the sterilized vial 52 and the inlet and outlet lines 72, 74. The sterilized pliable container 68 in the form of bag or pouch may be made of any suitable polymeric material, such as but not limited to PVC, and may be sterilized by ethylene oxide, alcohol, gamma ray radiation, or other suitable methods. The sterilized pliable container 68 may enclose at least the sterilized vial 52, the piercing member 58, portions of the inlet and outlet lines 72, 74 connected to the piercing member 58, and the sterilized holder 70, if any. If the piercing member 58 is designed to be pushed against the sterilized vial 52 at the time of use, then there may be some slack in the inlet and outlet lines 72, 74 inside the sterilized pliable container 68 to accommodate the movement of the piercing member 58. Other fluidic components, such as but not limited to the manual air pump 66, the optional air filter 78, and the optional check valves 80, 82, may also be hermetically sealed within the sterilized pliable container 68. The free end of the outlet line 74, which is welded close or terminated with a male or female portion of the aseptic connector 76, will be aseptically connected to an external line at the time of use and therefore should not be sealed in the sterilized pliable container 68. The sterilized vial 52, the piercing member 58 of the sterilized fluidic assembly, and the sterilized holder 70, onto which the sterilized vial 52 and the piercing member 58 are separately mounted, may be hermetically sealed in the sterilized pliable container 68 in an aseptic or sterile environment to preserve the sterility of the components sealed therein. The system 50 may be discarded after the liquid substance 54 is transferred from the sterilized vial 52 to the receiving container (i.e. single-use application).
Manufacturing of the system 50 will now be described with reference to
At step 106, a fluidic assembly is provided that includes a piercing member 58 including therein first and second channels 60, 62 and having a tip end 64 that can operably puncture through the sterilized septum 56, the first and second channels having first and second channel openings at the tip end 64 of the piercing member 58; a manual air pump 66; an inlet line 72 fluidically connects the manual air pump 66 to the first channel 60 of the piercing member 58; and an outlet line 74 fluidically connected to the second channel 62 of the piercing member 58 at one end and hermetically sealed at the other end, as described above with reference to
After providing the fluidic assembly, the fluidic assembly is sterilized by a suitable means, such as but not limited to heat, steam, or gamma ray radiation, at step 108.
Since the sterilization of the vial 52 is independent of the sterilization of the fluidic assembly, steps 102/104 and steps 106/108 can be carried out in the reversed order (i.e., steps 106/108 and then steps 102/104) or simultaneously.
Next, at step 110, the sterilized vial 52 and the sterilized fluidic assembly are assembled, and the sterilized vial 52 and the piercing member 58 are hermetically sealed in a sterilized pouch 68 in an aseptic or sterile environment. The sterilized pouch 68 allows the piercing member 58 to puncture the sterilized septum 56 without breaching the sterilized pouch 68 when one of the sterilized vial 52 and the piercing member 58 is manually pushed against the other one of the sterilized vial 52 and the piercing member 58 from the exterior of the sterilized pouch 68.
The sterilized vial 52 and the piercing member 58 may be separately mounted on a sterilized holder 70 that provides a guiding mechanism for the piercing member 58 to puncture the sterilized septum 56 of the sterilized vial 52 in the sterilized pouch 68. The sterilized holder 70, together with the sterilized vial 52 and the piercing member 58, may be hermetically sealed in the sterilized pouch 68 at step 110.
Operation of the system 50 will now be described with reference to
The system 50 may further include a sterilized holder 70. The sterilized vial 52 and the piercing member 58 may be separately mounted on a sterilized holder 70 that provides a guiding mechanism for the piercing member 58 to puncture the sterilized septum 56 of the sterilized vial 52 in the sterilized pouch 68. The sterilized holder 70, together with the sterilized vial 52 and the piercing member 58, may be hermetically sealed in the sterilized pouch 68. The sterilized holder 70 may be made of any moldable material that has sufficient mechanical rigidity and can withstand the sterilization process, such as but not limited to thermoplastic materials.
Next, at step 124, the outlet line 74 is aseptically connected to an external line 84 for receiving the liquid substance 54. The other end of the external line 84 may be connected to a receiving container (not shown). For the outlet line 74 sealed by thermal welding, this may be carried out by using a commercial tube welder that maintains the sterility of the connection. For the outlet line 74 that uses an aseptic connector, this may be carried out by connecting the male or female half of the aseptic connector 76 attached to the free end of the outlet line 74 to the opposite half of the aseptic connector 76 attached to the external line 84.
At step 126, the sterilized septum 56 is punctured with the piercing member 58 by manually pushing one of the sterilized vial 52 and the piercing member 58 against the other one of the sterilized vial 52 and the piercing member 58 from an exterior of the sterilized pouch 68 without breaching the sterilized pouch 68, thereby aseptically establishing fluidic connections between the sterilized vial 52 and the inlet and outlet lines 72, 74. Steps 124 and 126 may be carried out in the reversed order or simultaneously.
After steps 124 and 126, the manual air pump 66 pushes air into the sterilized vial 52 oriented in an inverted position (i.e., the second channel 62 of the piercing member 58 is submerged in the liquid substance 54) to propel the liquid substance 54 in the sterilized vial 52 through the outlet line 74 and the external line 84 and into the receiving container at step 128. If only a portion of the liquid substance 54 in the sterilized vial 52 needs to be transferred to the receiving container, the sterilized vial 52 may be reoriented in an upright position (i.e., the second channel 62 of the piercing member 58 is not covered by the liquid substance 54) after the portion of the liquid substance 54 has been transferred out of the sterilized vial 52. After the sterilized vial 52 is reoriented in the upright position, the manual air pump 66 may continue to inject air into the sterilized vial 52, thereby pushing the residual liquid substance 54 remained in the outlet line 74 and the external line 84 into the receiving container without further draining the liquid substance 54 remained the sterilized vial 52. In an embodiment, the manual air pump 66 is a syringe.
The following examples are provided to illustrate, but not limit the invention.
The sterilized fluidic assembly comprises a pair of piercing members 58A, 58B, each of which includes therein a first channel 60A, 60B and a second channel 62A, 62B and having a tip end 64A, 64B that can operably puncture through the sterilized septum 56A, 56B, as shown in
Referring back to
The sterilized vials 52A, 52B, the sterilized holder 70A, and a part of the sterilized fluidic assembly including the piercing members 58A, 58B, the outlet lines 74A, 74B connected thereto, the check valves 82A, 82B, the three-way connector 152 connected to the outlet lines 74A, 74B, and portions of the inlet lines 72A, 72B are hermetically sealed inside the sterilized pouch 68 to preserve sterility. The inlet lines 72A, 72B fluidically connect the syringes 66A, 66B disposed outside the sterilized pouch 68 to the piercing members 58A, 58B disposed inside the sterilized pouch 68 via the pass-through connectors 156A, 156B. The three-way connector 152 disposed inside the sterilized pouch 68 is connected to one end of the pass-through connector 156C, the other end of which is connected to the integrated outlet line 74C disposed outside the sterilized pouch 68. The pass-through connectors 156A-156C may go through the sealed sterilized pouch 68 along a seam thereof.
Operation of the system 150 for aseptically transferring the liquid substances in the sterilized vials 52A, 52B to a receiving container will now be described with reference to
The sterilized fluidic assembly comprises a pair of piercing members 58A, 58B, each of which includes therein a first channel 60A, 60B and a second channel 62A, 62B and having a tip end 64A, 64B that can operably puncture through the sterilized septum 56A, 56B, as shown in
Referring back to
The sterilized vials 52A, 52B, the sterilized holder 70B, and a part of the sterilized fluidic assembly including the piercing members 58A, 58B, the outlet lines 74A, 74B connected thereto, the check valves 82A, 82B, the three-way connector 152 connected to the outlet lines 74A, 74B, and portions of the inlet lines 72A, 72B are hermetically sealed inside the sterilized pouch 68 to preserve sterility. The inlet lines 72A, 72B fluidically connect the syringes 66A, 66B disposed outside the sterilized pouch 68 to the piercing members 58A, 58B disposed inside the sterilized pouch 68 via the pass-through connectors 156A, 156B. The three-way connector 152 disposed inside the sterilized pouch 68 is connected to one end of the pass-through connector 156C, the other end of which is connected to the integrated outlet line 74C disposed outside the sterilized pouch 68. The pass-through connectors 156A-156C may go through the sealed sterilized pouch 68 along a seam thereof.
Operation of the system 170 for aseptically transferring the liquid substances in the sterilized vials 52A, 52B to a receiving container will now be described with reference to
The sterilized fluidic assembly comprises a pair of piercing members 58A, 58B, each of which includes therein a first channel 60A, 60B and a second channel 62A, 62B and having a tip end 64A, 64B that can operably puncture through the sterilized septum 56A, 56B, as shown in
Referring back to
The sterilized vials 52A, 52B, the sterilized holder 70C, and a part of the sterilized fluidic assembly including the piercing members 58A, 58B, the outlet lines 74A, 74B connected thereto, the check valves 82A, 82B, the three-way connector 152 connected to the outlet lines 74A, 74B, and portions of the inlet lines 72A, 72B are hermetically sealed inside the sterilized pouch 68 to preserve sterility. The inlet lines 72A, 72B fluidically connect the syringes 66A, 66B disposed outside the sterilized pouch 68 to the piercing members 58A, 58B disposed inside the sterilized pouch 68 via the pass-through connectors 156A, 156B. The three-way connector 152 disposed inside the sterilized pouch 68 is connected to one end of the pass-through connector 156C, the other end of which is connected to the integrated outlet line 74C disposed outside the sterilized pouch 68. The pass-through connectors 156A-156C may go through the sealed sterilized pouch 68 along a seam thereof.
Operation of the system 190 for aseptically transferring the liquid substances in the sterilized vials 52A, 52B to a receiving container will now be described with reference to
The present invention allows the aseptic transfer process described herein to be carried out in a non-aseptic or non-sterile environment because the sterilized vials 52, 52A, 52B and the piercing members 58, 58A, 58B are sealed in the sterilized pouch 68 and isolated from the environment. Fluidic connections can be made between the sterilized vials 52, 52A, 52B and the inlet and outlet lines 72, 72A, 72B, 74, 74A, 74B, 74C in the sterilized pouch 68 regardless of the surrounding environment.
While the present invention has been shown and described with reference to certain preferred embodiments, it is to be understood that those skilled in the art will no doubt devise certain alterations and modifications thereto which nevertheless include the true spirit and scope of the present invention. Thus the scope of the invention should be determined by the appended claims and their legal equivalents, rather than by examples given.
Any element in a claim that does not explicitly state “means for” performing a specified function, or “step for” performing a specific function, is not to be interpreted as a “means” or “step” clause as specified in 35 U.S.C. § 112, 16. In particular, the use of “step of” in the claims herein is not intended to invoke the provisions of 35 U.S.C. § 112, 6.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3872730 | Ringrose | Mar 1975 | A |
| 7418981 | Baker et al. | Sep 2008 | B2 |
| 7900658 | Osborne et al. | Mar 2011 | B2 |
| 9456956 | Webster | Oct 2016 | B1 |
| 9597260 | Ivosevic et al. | Mar 2017 | B2 |
| 9925333 | Hooven et al. | Mar 2018 | B2 |
| 10182969 | Arnott et al. | Jan 2019 | B2 |
| 10695490 | Perazzo et al. | Jun 2020 | B2 |
| 11759572 | Genosar | Sep 2023 | B2 |
| 20090306621 | Thome, Jr. | Dec 2009 | A1 |
| 20130225903 | Franci | Aug 2013 | A1 |
| 20220370289 | McLoughlin | Nov 2022 | A1 |
| 20240366476 | Hadad | Nov 2024 | A1 |
| 20240423873 | Thorne, Jr. | Dec 2024 | A1 |